| 5 | 1/1 | 返回列表 |
| 查看: 2892 | 回復: 4 | |||
gaojingmei金蟲 (著名寫手)
|
[求助]
阿奇霉素片和膠囊的原研廠家?
|
|
阿奇霉素片和膠囊的原研廠家是究竟是哪家呢?是同一廠家?還是不同廠家?Pliva和輝瑞到底哪個才是原研廠家? 在美國是輝瑞上市早,Pliva是仿制,但在其他國家和地區(qū)的批準上市情況如何呢? 請各位大俠鼎力相助! |
鐵桿木蟲 (職業(yè)作家)
|
Select all Show Checked azithromycin Updated on 06-MAR-2012. Originator: PLIVA dd . Highest Dev Status: Launched. DR azithromycin dihydrate + chloroquine phosphate (fixed-dose combination/ Plasmodium falciparum malaria), Pfizer/ Medicines For Malaria Venture/ London School of Hygiene and Tropical Medicine Updated on 02-MAR-2012. Originator: Medicines for Malaria Venture . Highest Dev Status: Phase 3 Clinical. DR azithromycin (ophthalmic sustained release, DuraSite), InSite Updated on 29-FEB-2012. Originator: InSite Vision Inc . Highest Dev Status: Launched. DR azithromycin (sustained-release, DuraSite, ocular infection), InSite Updated on 29-FEB-2012. Originator: InSite Vision Inc . Highest Dev Status: Discovery. DR azithromycin + dexamethasone (sustained release, DuraSite), InSite Updated on 29-FEB-2012. Originator: InSite Vision Inc . Highest Dev Status: Phase 3 Clinical. DR JP-02 Updated on 13-JAN-2012. Originator: Bioagency AG . Highest Dev Status: No Development Reported. DR azithromycin (dermal formulation, Lyme disease), Ixodes Updated on 08-SEP-2011. Originator: Ixodes Gmbh . Highest Dev Status: Phase 2 Clinical. DR azithromycin + dexamethasone (sustained-release, DuraSite, bacterial ear infection), InSite Updated on 25-AUG-2011. Originator: InSite Vision Inc . Highest Dev Status: Discontinued. DR azithromycin-based macrolide antibiotics (malaria), GlaxoSmithKline/Medicines for Malaria Venture Updated on 24-AUG-2011. Originator: GlaxoSmithKline plc . Highest Dev Status: No Development Reported. DR azithromycin (sustained release, microsphere formulation), Pfizer Updated on 31-MAY-2011. Originator: Pfizer Inc . Highest Dev Status: Launched. DR azithromycin (Solumer nanoparticle, bacterial infection), Solubest Updated on 02-SEP-2009. Originator: Solubest Ltd . Highest Dev Status: No Development Reported. |
木蟲 (職業(yè)作家)
鐵桿木蟲 (職業(yè)作家)
鐵桿木蟲 (正式寫手)
| 阿奇霉素最先是由克羅地亞普利瓦公司研制合成,并率先在前南斯拉夫上市的。為了取得更大的經(jīng)濟效益,原研發(fā)公司將全球的生產(chǎn)和市場開發(fā)權進行了轉讓,由美國輝瑞公司和意大利Sigma-Tau公司授讓進行全球開發(fā)。輝瑞公司在取得了全球開發(fā)權后,其獲批的阿奇霉素商品名為希舒美。08年,希舒美在阿奇霉素的市場占有率達到30.78%。 |
| 5 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考博] 26申博自薦 +3 | whh869393 2026-03-24 | 3/150 |
|
|---|---|---|---|---|
|
[考研] 材料調劑 +5 | 匹克i 2026-03-23 | 5/250 |
|
|
[考研] 一志愿南航材料專317分求調劑 +4 | 炸呀炸呀炸薯條 2026-03-23 | 4/200 |
|
|
[考研] 一志愿北京化工大學 070300 學碩 336分 求調劑 +7 | vv迷 2026-03-22 | 7/350 |
|
|
[考研] 材料專碩找調劑 +3 | 哈哈哈吼吼吼哈 2026-03-23 | 3/150 |
|
|
[考研] 303求調劑 +4 | 元夕元 2026-03-20 | 4/200 |
|
|
[考研] 336化工調劑 +4 | 王大坦1 2026-03-23 | 5/250 |
|
|
[考研] 280分求調劑 一志愿085802 +4 | PUMPT 2026-03-22 | 7/350 |
|
|
[考研] 311求調劑 +3 | 26研0 2026-03-20 | 3/150 |
|
|
[考研] 求調劑 +3 | 13341 2026-03-20 | 3/150 |
|
|
[考研] 材料學碩333求調劑 +3 | 北道巷 2026-03-18 | 3/150 |
|
|
[考研] 302求調劑 +12 | 呼呼呼。。。。 2026-03-17 | 12/600 |
|
|
[考研] 一志愿重慶大學085700資源與環(huán)境總分308求調劑 +7 | 墨墨漠 2026-03-20 | 7/350 |
|
|
[考研] 301求調劑 +10 | yy要上岸呀 2026-03-17 | 10/500 |
|
|
[考研] 初始318分求調劑(有工作經(jīng)驗) +3 | 1911236844 2026-03-17 | 3/150 |
|
|
[考研] 304求調劑 +7 | 司空. 2026-03-18 | 7/350 |
|
|
[考研]
|
然11 2026-03-19 | 4/200 |
|
|
[考研] 329求調劑 +9 | 想上學吖吖 2026-03-19 | 9/450 |
|
|
[考研]
|
簡木ChuFront 2026-03-19 | 8/400 |
|
|
[考研] 本科鄭州大學物理學院,一志愿華科070200學碩,346求調劑 +4 | 我不是一根蔥 2026-03-18 | 4/200 |
|